Trulieve CEO: Medical Cannabis Transition | Mad Money | CNBC
It’s a medical marijuana company helping over 80,000 patients and you may have never heard of it. Jim Cramer looks into Trulieve and what it can tell us about the…
GW Pharmaceuticals CEO: ‘Real Science’ in Cannabis | Mad Money | CNBC
Canada’s marijuana legalization may be all the rage, but one drug company has been working for years to create real cannabis-based medicine. Jim Cramer hears from GW Pharma’s CEO about…
Green Growth Brands CEO: Breaking into Cannabis Retail | Mad Money | CNBC
He’s spent time in the C-Suite at Victoria’s Secret and DSW, and now, he’s turning his attention to cannabis. Jim Cramer finds out what retailers can bring to the table…
Green Thumb Industries CEO: ‘Credentializing’ Cannabis | Mad Money | CNBC
The whole cannabis cohort has been smoking hot, but not all pot stocks are created equal. Jim Cramer checks in with the CEO of growth-focused Green Thumb Industries to try…
Cronos CEO on nicotine vaping versus cannabis vaping
Cronos CEO Mike Gorenstein tells Jim Cramer what his company is doing different to enter the cannabis vaping space, particularly in the Canadian market.